Korean Stock Flows

Prestige Biopharma Limited Kdr (KRX: 950210)

프레스티지바이오파마 KOSPI Biotech & Pharma 자연과학 및 공학 연구개발업
Close (Oct 13, 2026)
₩5,540
-1.77%
Market cap
₩0T ($0.2B)
52-week range
₩4,945 – ₩14,120
P/E (trailing) · P/B · Div yield
– · – · –

Who is buying Prestige Biopharma Limited Kdr?

Between Sep 10, 2026 and Oct 13, 2026 (20 trading sessions), foreign investors net bought ₩0.1bn ($0M) of Prestige Biopharma Limited Kdr, the 195th largest foreign net purchase among 832 KOSPI stocks. Institutions net bought ₩0.0bn ($0M) and retail investors net sold ₩0.1bn ($0M) over the same window. Foreigners were net buyers on 13 of the 20 sessions.

Foreign investors hold 63.64% of Prestige Biopharma Limited Kdr's listed shares (KRX ownership data as of Oct 13, 2026), up from 63.53% twenty sessions earlier and 63.58% a year ago.

The stock closed at ₩5,540 on Oct 13, 2026: -12.48% over 20 sessions, -56.89% year-to-date, -57.15% over one year. The 52-week range is ₩4,945 – ₩14,120.

Prestige Biopharma Limited Kdr share price, last 60 trading days (KRW)
7,330 6,520 5,710 4,900 Jul 13 Aug 26 Oct 13
Daily foreign investor net purchases, last 60 trading days
+0.2bn +0.1bn -0.1bn -0.2bn Jul 13 Aug 26 Oct 13
View chart data as a table
Date Close Foreign net Institutions Retail
2026-10-13 ₩5,540 +₩0.1bn ₩0.0bn ₩-0.1bn
2026-10-12 ₩5,640 ₩-0.1bn ₩0.0bn +₩0.0bn
2026-10-08 ₩5,960 +₩0.0bn +₩0.0bn ₩-0.0bn
2026-10-07 ₩5,930 +₩0.1bn ₩-0.0bn ₩-0.0bn
2026-10-06 ₩5,880 ₩-0.1bn +₩0.0bn +₩0.1bn
2026-10-02 ₩6,100 ₩-0.0bn ₩0.0bn +₩0.0bn
2026-10-01 ₩6,150 +₩0.1bn +₩0.0bn ₩-0.1bn
2026-09-30 ₩5,970 +₩0.0bn +₩0.0bn ₩-0.0bn
2026-09-29 ₩6,040 +₩0.0bn +₩0.0bn ₩-0.0bn
2026-09-28 ₩6,060 +₩0.0bn ₩0.0bn ₩-0.0bn
2026-09-23 ₩5,970 +₩0.0bn ₩-0.0bn ₩-0.0bn
2026-09-22 ₩5,860 +₩0.0bn ₩-0.0bn ₩-0.0bn
2026-09-21 ₩5,820 ₩-0.0bn +₩0.0bn +₩0.0bn
2026-09-18 ₩5,980 ₩-0.0bn ₩0.0bn +₩0.0bn
2026-09-17 ₩6,000 +₩0.0bn ₩0.0bn ₩-0.0bn
2026-09-16 ₩5,950 +₩0.0bn +₩0.0bn ₩-0.0bn
2026-09-15 ₩5,960 +₩0.0bn ₩-0.0bn ₩-0.0bn
2026-09-14 ₩6,130 +₩0.0bn ₩-0.0bn ₩-0.0bn
2026-09-11 ₩6,190 ₩-0.1bn +₩0.0bn +₩0.1bn
2026-09-10 ₩6,400 ₩-0.0bn ₩-0.0bn +₩0.0bn
2026-09-09 ₩6,330 ₩-0.0bn ₩0.0bn +₩0.0bn
2026-09-08 ₩6,350 +₩0.1bn +₩0.0bn +₩0.0bn
2026-09-07 ₩6,450 +₩0.0bn +₩0.0bn +₩0.0bn
2026-09-04 ₩6,500 ₩-0.0bn ₩-0.0bn +₩0.0bn
2026-09-03 ₩6,470 ₩-0.1bn ₩-0.0bn +₩0.2bn
2026-09-02 ₩6,720 ₩-0.1bn +₩0.0bn +₩0.1bn
2026-09-01 ₩6,520 +₩0.0bn ₩-0.0bn +₩0.0bn
2026-08-31 ₩6,500 ₩-0.0bn ₩0.0bn +₩0.0bn
2026-08-28 ₩6,430 +₩0.1bn ₩-0.0bn ₩-0.1bn
2026-08-27 ₩6,250 +₩0.0bn +₩0.0bn ₩-0.0bn
2026-08-26 ₩6,260 +₩0.0bn ₩0.0bn ₩-0.0bn
2026-08-25 ₩6,210 +₩0.0bn ₩0.0bn ₩-0.0bn
2026-08-24 ₩6,130 +₩0.0bn ₩-0.0bn ₩-0.0bn
2026-08-21 ₩6,070 ₩-0.0bn ₩0.0bn +₩0.0bn
2026-08-20 ₩6,310 ₩-0.0bn +₩0.0bn +₩0.0bn
2026-08-19 ₩6,270 ₩-0.1bn ₩-0.0bn +₩0.1bn
2026-08-18 ₩6,500 ₩-0.2bn ₩0.0bn +₩0.2bn
2026-08-14 ₩7,200 +₩0.1bn +₩0.0bn ₩-0.1bn
2026-08-13 ₩6,890 ₩-0.0bn ₩-0.0bn +₩0.0bn
2026-08-12 ₩6,890 ₩-0.1bn +₩0.0bn +₩0.1bn
2026-08-11 ₩6,840 +₩0.0bn ₩-0.0bn ₩-0.0bn
2026-08-10 ₩6,600 ₩-0.0bn +₩0.0bn +₩0.0bn
2026-08-07 ₩6,600 +₩0.0bn ₩-0.0bn +₩0.0bn
2026-08-06 ₩6,610 +₩0.0bn ₩-0.0bn +₩0.0bn
2026-08-05 ₩6,500 ₩-0.1bn +₩0.0bn +₩0.1bn
2026-08-04 ₩6,340 ₩-0.0bn ₩-0.0bn +₩0.0bn
2026-08-03 ₩5,950 ₩-0.1bn +₩0.0bn +₩0.1bn
2026-07-31 ₩6,400 +₩0.1bn ₩0.0bn ₩-0.1bn
2026-07-30 ₩5,720 ₩-0.1bn ₩-0.0bn +₩0.1bn
2026-07-29 ₩5,550 ₩-0.1bn +₩0.0bn +₩0.1bn
2026-07-28 ₩5,550 ₩-0.0bn ₩-0.0bn +₩0.0bn
2026-07-27 ₩5,610 ₩-0.0bn ₩0.0bn +₩0.0bn
2026-07-24 ₩5,250 ₩-0.0bn +₩0.0bn +₩0.0bn
2026-07-23 ₩5,260 +₩0.0bn ₩-0.0bn ₩-0.0bn
2026-07-22 ₩5,100 +₩0.0bn +₩0.0bn ₩-0.0bn
2026-07-21 ₩5,030 ₩-0.1bn ₩0.0bn +₩0.1bn
2026-07-20 ₩5,210 +₩0.0bn ₩-0.0bn ₩-0.0bn
2026-07-16 ₩5,290 +₩0.0bn +₩0.0bn ₩-0.0bn
2026-07-15 ₩5,370 +₩0.1bn ₩-0.0bn ₩-0.1bn
2026-07-14 ₩5,130 ₩-0.0bn +₩0.0bn +₩0.0bn
2026-07-13 ₩5,530 +₩0.0bn ₩0.0bn +₩0.0bn

Investor flows summary

Window Foreign (USD) Institutions Retail
1 day +₩0.1bn +$0M ₩0.0bn ₩-0.1bn
5 days +₩0.0bn +$0M ₩0.0bn ₩-0.0bn
20 days +₩0.1bn +$0M +₩0.0bn ₩-0.1bn

Positive = net buying, negative = net selling. Values aggregate the KRX main board and the NXT alternative venue.

Frequently asked questions

Are foreign investors buying Prestige Biopharma Limited Kdr stock?

Over the last 5 sessions foreign investors net bought ₩0.0bn ($0M) of Prestige Biopharma Limited Kdr; over 60 sessions they net sold ₩0.3bn ($0M); since Jan 1, 2026 they net sold ₩0.8bn ($1M). Over 20 sessions the stock is the 195th largest foreign net purchase among 832 KOSPI stocks.

How much of Prestige Biopharma Limited Kdr do foreign investors own?

Foreign investors own 63.64% of Prestige Biopharma Limited Kdr's shares as of Oct 13, 2026, versus 63.58% one year earlier. The figure is KRX's daily foreign holdings divided by listed shares, and it reflects trades settled through the previous session.

Who is on the other side — institutions or retail investors?

Over 20 sessions institutions net bought ₩0.0bn ($0M) and retail investors net sold ₩0.1bn ($0M) of Prestige Biopharma Limited Kdr. Retail investors have been supplying the shares that foreigners and institutions are buying.

Is Prestige Biopharma Limited Kdr listed on KOSPI or KOSDAQ?

Prestige Biopharma Limited Kdr (프레스티지바이오파마) trades on KOSPI under KRX code 950210 in the Biotech & Pharma group, with a market capitalization of ₩0T ($0.2B). Daily net flows by investor type are published by KRX after each session and combine the KRX main board with the NXT venue.

Annual financials

Fiscal year Revenue YoY Operating profit Net income
2024 – – -₩65bn (-$49M) -₩57bn (-$43M)
2025 ₩14bn ($10M) – -₩65bn (-$49M) ₩4bn ($3M)
2026 ₩28bn ($21M) +101.50% -₩100bn (-$75M) -₩131bn (-$99M)

Consolidated (K-IFRS) where available, from DART regulatory filings. USD figures converted at the current rate (₩1333.09/$) for reference only.

← All foreign investor flows